Our Team in the News


BioPlan Associates' Ronald Rader

Ron Rader, Sr. Dir. Technical Research: named Editor-in-Chief of Biopharmaceuticals a new peer-reviewed journal from Landes Bioscience. Biopharmaceuticals is the first and only peer-reviewed journal about biopharmaceuticals. Biopharmaceuticals seeks submission of articles concerning biopharmaceuticals and the industry. Please contact the Editor-in-Chief if interested in submitting an article.


BioPlan Associates' Faiz Kermani PhD

Dr Faiz Kermani, Advisory Board: Has helped establish the "Global Health Education Foundation" (GHEF), a not-for-profit healthcare charity to improve educational resources and training for healthcare professionals in developing countries.
At least 1.3 billion people worldwide lack access to the most basic healthcare. The new non-profit foundation, Global Health Education Foundation, aims to tackle such issues. As President of GHEF, Dr Kermani is supporting the R&D focus of the charity to reduce health disparities among developing countries. In particular, the lack of appropriate educational resources and training opportunities for healthcare professionals. http://www.globalhef.org


BioPlan Associates' Managing Director Eric Langer

Eric Langer, Managing Partner: On Advisory Board of “BioProcess Asia Pacific Conference” July 2010 Singapore.
The Biopharmaceutical market in Asia pacific is growing at a rate among the highest in the globe. This is creating a strong need for production of biopharmaceuticals at higher qualities and volumes. Bioprocess AsiaPacific brings together global leaders within biopharmaceutical industry to explore dynamic strategies, benchmark technologies and analyze sustaining the growth of the industry. http://fleminggulf.com/conference/life-science/BioProcessAsiaPacific.


Publications, Reports and Books

Articles

2013


Critical Innovation BioProcessing Trends For 2014
Life Science Leader, December 2013; E. Langer
Key Outsourcing Trends to Watch This Year
Pharmaceutical Outsourcing, January 2014; E. Langer
Biopharmas Increasingly Satisfied With Vendors Of Single-Use Products
Life Science Leader, December 2013; E. Langer
CMOs Demanding More Innovations
Contract Pharma, November 2013
Innovation In Stainless-Steel Bioprocessing
Life Science Leader, October 2013; E. Langer and R. Rader
Seeking Innovation to Solve Persistent Problems
Pharmaceutical Manufacturing, November 2013; E. Langer
Bio-CMO Capacity Constraints
Contract Pharma, September 2013; E. Langer
Industry Adoption of Membrane Adsorbers
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, October 2013; E. Langer
Client Relationships: How CMOs Can Avoid The Pitfalls
Life Science Leader, October 2013; E. Langer
Innovation In Alternative Chromatography
Life Science Leader, October 2013; E. Langer
PAT Adoption Hurdles Remain
Pharmaceutical Manufacturing, October 2013; E. Langer
Making the Best of a Bad CMO-Client Relationship
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, September 2013; E. Langer
Innovation In Expression Systems Yields Increase Productivity
Life Science Leader, August 2013; E. Langer
Bioprocessing Advances in Vaccine Manufacture
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, September 2013; E. Langer and R. Rader
What Happened to Outsourcing in Asia?
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, August 2013; E. Langer
Innovation In Disposable Connectors
Life Science Leader, July 2013; E. Langer
Demand For Innovation In High-Value Bioprocessing
Life Science Leader, June 2013; E. Langer
Disposable Applications Penetrate Biomanufacturing Market
Pharmaceutical Manufacturing, June 2013; E. Langer
Keeping New Technologies Coming
BioProcess International, June 2013; E. Langer
Outsourcing's Modest Role as a Cost-Containment Strategy
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, May 2013; E. Langer
Outsourcing of Fill-Finish Operations Continues
Pharmaceutical Processing, April 2013; E. Langer
Single-use Bioprocessing Sensor Innovation Is In Need
Life Science Leader, April 2013; E. Langer
Vendors Ignore Calls For Innovation In Assays
Life Science Leader, April 2013; E. Langer
Biopharma Continues Globalization Efforts
Global Corporate Xpansion, April 2013; E. Langer
Outsourcing of Non-traditional Protein Expression Systems Increases
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, April 2013; E. Langer
The Big Squeeze
European Biopharmaceutical Review, Spring 2013; E. Langer
Fill-Finish Innovation: Showing Sparks of Life
Contract Pharma, March 2013; E. Langer and R. Rader
Innovation In Assays And Analytical Methods Urgently Needed
Life Science Leader, February 2013; E. Langer
Biopharmas Increasingly Satisfied With Vendors Of Single-Use Products
Pharmaceutical Online, February 2013; E. Langer
The Future of BioPharma
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, February 2013; E. Langer
Offshoring Biomanufacturing
Pharmaceutical Technology, February 2013; E. Langer
Sponsors Look to Asia for Potential Contract Partners
BioProcessing International, January 2013; E. Langer

> 2012

> 2011

> 2010

> 2009

> 2008

> 2007 and earlier

> Technical Reports

  • Stem Cell Industry Opportunities [Spring 2002]
    This report was published in conjunction with MarketResearch.com
  • Tissue Engineering—An Industry Assessment [Spring 2001]
    This report was published in conjunction with MarketResearch.com
  • Cell and Tissue Culture Media, Sera, and Reagents
    Medical and Healthcare Marketplace Guide Research Reports 2001
  • Genomics
    Medical and Healthcare Marketplace Guide Research Reports 2001
  • Laboratory Animals
    Medical and Healthcare Marketplace Guide Research Reports 2001
  • Tissue Engineering
    Medical and Healthcare Marketplace Guide Research Reports 2001
  • Transgenic Animals
    Medical and Healthcare Marketplace Guide Research Reports 2001